This is not the most recent version of the article. View current version (17 MAR 2010)

Standard Article

Vitamin C for preventing and treating the common cold

  1. RM Douglas Director*,
  2. EB Chalker,
  3. B Treacy

Editorial Group: Cochrane Acute Respiratory Infections Group

Published Online: 19 JUL 2004

DOI: 10.1002/14651858.CD000980

How to Cite

Douglas RM, Chalker EB, Treacy B. Vitamin C for preventing and treating the common cold. The Cochrane Database of Systematic Reviews 1998, Issue 2. Art. No.: CD000980. DOI: 10.1002/14651858.CD000980.

Author Information

  1. The Australian National University, National Centre for Epidemiology and Population Health, Canberra, ACT, AUSTRALIA

*RM Douglas, Director, National Centre for Epidemiology and Population Health, The Australian National University, Canberra, ACT, 0200, AUSTRALIA. Bob.Douglas@anu.edu.au.

Publication History

  1. Published Online: 19 JUL 2004

SEARCH

This is not the most recent version of the article.View current version (17 Mar 2010)

 

Abstract

  1. Top of page
  2. Abstract
  3. Synopsis

Background

The role of oral ascorbic acid (vitamin C) in the prevention and treatment of colds remains controversial despite many controlled trials. There have also been a number of efforts to synthesize and/or overview the results of these trials, and controversy over what these overviews tell us.

Objectives

The objective of this review was to answer the following two questions:
(1) Does regular high dosage supplementation with vitamin C reduce the incidence of colds?
(2) Does taking vitamin C in high doses at the onset of a cold have a therapeutic effect?

Search strategy

This review currently deals only with published trials from two previously published reviews by Kleijnen 1989 and Hemila 1992.

Selection criteria

Randomised and non-randomised trials of vitamin C taken to prevent or treat the common cold.

Data collection and analysis

Two reviewers independently extracted data and assessed trial quality.

Main results

Thirty trials were included. The quality of the included trials was variable. Vitamin C in doses as high as one gram daily for several winter months, had no consistent beneficial effect on incidence of the common cold. For both preventive and therapeutic trials, there was a consistently beneficial but generally modest therapeutic effect on duration of cold symptoms. This effect was variable, ranging from -0.07% to a 39% reduction in symptom days. The weighted difference across all of the studies revealed a reduction of a little less than half a symptom day per cold episode, representing an 8% to 9% reduction in symptom days. There was no clear indication of the relative benefits of different regimes or vitamin C doses. However in trials that tested vitamin C after cold symptoms occurred, there was some evidence that a large dose produced greater benefits than lower doses.

Reviewers' conclusions

Long term daily supplementation with vitamin C in large doses daily does not appear to prevent colds. There appears to be a modest benefit in reducing duration of cold symptoms from ingestion of relatively high doses of vitamin C. The relation of dose to therapeutic benefit needs further exploration.

 

Synopsis

  1. Top of page
  2. Abstract
  3. Synopsis

Synopsis

Vitamin C does not prevent the common cold, but very high doses probably shorten the length of the illness

Controversy continues over the role of oral ascorbic acid (vitamin C) in preventing and treating colds. Colds are caused by a number of viruses. There is currently no proven cure, although symptoms can be treated. The review found that long-term supplementation with vitamin C in large daily doses does not appear to prevent colds. However, taking relatively high doses of vitamin C probably shortens the length of the illness. More research is needed on how high the dose needs to be to help.